{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:06:25Z","timestamp":1792317985868,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["KFOC 190004"],"award-info":[{"award-number":["KFOC 190004"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 173512"],"award-info":[{"award-number":["PJT 173512"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00125-021-05538-9","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T04:02:45Z","timestamp":1628481765000},"page":"2589-2601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-4666","authenticated-orcid":false,"given":"Kana N.","family":"Miyata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-7987","authenticated-orcid":false,"given":"Chao-Sheng","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-8900","authenticated-orcid":false,"given":"Michifumi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-3534","authenticated-orcid":false,"given":"Janos G.","family":"Filep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-2703","authenticated-orcid":false,"given":"Julie R.","family":"Ingelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-6970","authenticated-orcid":false,"given":"Shao-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-454X","authenticated-orcid":false,"given":"John S. D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"2","key":"5538_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2337\/dbi18-0007","volume":"68","author":"R Alicic","year":"2019","unstructured":"Alicic R, Neumiller J, Johnson E, Dieter B, Tuttle K (2019) Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease. Diabetes 68(2):248\u2013257. https:\/\/doi.org\/10.2337\/dbi18-0007","journal-title":"Diabetes"},{"issue":"1","key":"5538_CR2","doi-asserted-by":"publisher","first-page":"F207","DOI":"10.1152\/ajprenal.00120.2019","volume":"317","author":"P Song","year":"2019","unstructured":"Song P, Huang W, Onishi A et al (2019) Knockout of Na(+)-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration. Am J Physiol Renal Physiol 317(1):F207\u2013F217. https:\/\/doi.org\/10.1152\/ajprenal.00120.2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"5538_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi S, Lachin J et al (2016) Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 375(4):323\u2013334. https:\/\/doi.org\/10.1056\/NEJMoa1515920","journal-title":"N Engl J Med"},{"issue":"7","key":"5538_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey K et al (2017) Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377(7):644\u2013657. https:\/\/doi.org\/10.1056\/NEJMoa1611925","journal-title":"N Engl J Med"},{"issue":"24","key":"5538_CR5","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine M, Neal B et al (2019) Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med 380(24):2295\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1811744","journal-title":"N Engl J Med"},{"issue":"15","key":"5538_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"issue":"5","key":"5538_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","volume":"129","author":"D Cherney","year":"2014","unstructured":"Cherney D, Perkins B, Soleymanlou N et al (2014) Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129(5):587\u2013597. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005081","journal-title":"Circulation"},{"issue":"1","key":"5538_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2017.04.011","volume":"26","author":"E Ferrannini","year":"2017","unstructured":"Ferrannini E (2017) Sodium-glucose co-transporters and their inhibition: clinical physiology. Cell Metab 26(1):27\u201338. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.011","journal-title":"Cell Metab"},{"issue":"3","key":"5538_CR9","doi-asserted-by":"publisher","first-page":"F449","DOI":"10.1152\/ajprenal.00431.2018","volume":"316","author":"M Pirklbauer","year":"2019","unstructured":"Pirklbauer M, Schupart R, Fuchs L et al (2019) Unraveling reno-protective effects of SGLT2 inhibition in human proximal tubular cells. Am J Physiol Renal Physiol 316(3):F449\u2013F462. https:\/\/doi.org\/10.1152\/ajprenal.00431.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"5538_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fendo.2019.00441","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang F, Zhao Y, Wang Q et al (2019) Dapagliflozin attenuates renal tubulointerstitial fibrosis associated with type 1 diabetes by regulating STAT1\/TGF\u03b21 signaling. Front Endocrinol (Lausanne) 10:441","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5538_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MNH.0b013e328359dbed","volume":"22","author":"N Ramkumar","year":"2013","unstructured":"Ramkumar N, Kohan DE (2013) Proximal tubule angiotensinogen modulation of arterial pressure. Curr Opin Nephrol Hypertens 22(1):32\u201336. https:\/\/doi.org\/10.1097\/MNH.0b013e328359dbed","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"5538_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1681\/ASN.2004080715","volume":"16","author":"C Wei","year":"2005","unstructured":"Wei C, Guo D, Zhang S, Ingelfinger J, Chan J (2005) Heterogenous nuclear ribonucleoprotein F modulates angiotensinogen gene expression in rat kidney proximal tubular cells. J Am Soc Nephrol 16(3):616\u2013628. https:\/\/doi.org\/10.1681\/ASN.2004080715","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"5538_CR13","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2337\/db11-1349","volume":"61","author":"C Lo","year":"2012","unstructured":"Lo C, Chang S, Chenier I et al (2012) Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61(10):2597\u20132608. https:\/\/doi.org\/10.2337\/db11-1349","journal-title":"Diabetes"},{"issue":"7","key":"5538_CR14","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/db16-1588","volume":"66","author":"C Lo","year":"2017","unstructured":"Lo C, Shi Y, Chenier I et al (2017) Heterogeneous nuclear ribonucleoprotein F stimulates Sirtuin-1 gene expression and attenuates nephropathy progression in diabetic mice. Diabetes 66(7):1964\u20131978. https:\/\/doi.org\/10.2337\/db16-1588","journal-title":"Diabetes"},{"issue":"1","key":"5538_CR15","doi-asserted-by":"publisher","first-page":"15765","DOI":"10.1038\/s41598-019-52323-1","volume":"9","author":"C Lo","year":"2019","unstructured":"Lo C, Miyata K, Zhao S et al (2019) Tubular deficiency of heterogeneous nuclear ribonucleoprotein F elevates systolic blood pressure and induces glycosuria in mice. Sci Rep 9(1):15765","journal-title":"Sci Rep"},{"issue":"3","key":"5538_CR16","doi-asserted-by":"publisher","first-page":"F788","DOI":"10.1152\/ajprenal.90515.2008","volume":"298","author":"S Gurley","year":"2010","unstructured":"Gurley S, Mach C, Stegbauer J et al (2010) Influence of genetic background on albuminuria and kidney injury in Ins2(+\/C96Y) (Akita) mice. Am J Physiol Renal Physiol 298(3):F788\u2013F795. https:\/\/doi.org\/10.1152\/ajprenal.90515.2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"5538_CR17","doi-asserted-by":"publisher","first-page":"F214","DOI":"10.1152\/ajprenal.00204.2005","volume":"290","author":"S Gurley","year":"2006","unstructured":"Gurley S, Clare S, Snow K, Hu A, Meyer T, Coffman T (2006) Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290(1):F214\u2013F222. https:\/\/doi.org\/10.1152\/ajprenal.00204.2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"5538_CR18","doi-asserted-by":"publisher","first-page":"F840","DOI":"10.1152\/ajprenal.00340.2011","volume":"302","author":"C Lo","year":"2012","unstructured":"Lo C, Liu F, Shi Y et al (2012) Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Am J Physiol Renal Physiol 302(7):F840\u2013F852. https:\/\/doi.org\/10.1152\/ajprenal.00340.2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"5538_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00125-013-2910-4","volume":"56","author":"S Abdo","year":"2013","unstructured":"Abdo S, Lo C, Chenier I et al (2013) Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia 56(7):1649\u20131660. https:\/\/doi.org\/10.1007\/s00125-013-2910-4","journal-title":"Diabetologia"},{"issue":"4","key":"5538_CR20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1210\/en.2016-1576","volume":"158","author":"A Ghosh","year":"2017","unstructured":"Ghosh A, Abdo S, Zhao S et al (2017) Insulin inhibits Nrf2 gene expression via heterogeneous nuclear ribonucleoprotein F\/K in diabetic mice. Endocrinology 158(4):903\u2013919. https:\/\/doi.org\/10.1210\/en.2016-1576","journal-title":"Endocrinology"},{"issue":"4","key":"5538_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","volume":"140","author":"K Kidokoro","year":"2019","unstructured":"Kidokoro K, Cherney D, Bozovic A et al (2019) Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging. Circulation 140(4):303\u2013315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037418","journal-title":"Circulation"},{"key":"5538_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2019.11.001","volume":"217","author":"K Miyata","year":"2020","unstructured":"Miyata K, Zhao X, Chang S et al (2020) Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease. Transl Res 217:1\u201310. https:\/\/doi.org\/10.1016\/j.trsl.2019.11.001","journal-title":"Transl Res"},{"issue":"1","key":"5538_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1681\/ASN.2010030246","volume":"22","author":"V Vallon","year":"2011","unstructured":"Vallon V, Platt K, Cunard R et al (2011) SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 22(1):104\u2013112. https:\/\/doi.org\/10.1681\/ASN.2010030246","journal-title":"J Am Soc Nephrol"},{"key":"5538_CR24","first-page":"149","volume-title":"Numerical density: shape and size of particles","author":"E Weibel","year":"1980","unstructured":"Weibel E (1980) Numerical density: shape and size of particles, vol 2. Academic Press, London, pp 149\u2013152"},{"issue":"2","key":"5538_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.kint.2018.09.026","volume":"95","author":"L Wang","year":"2019","unstructured":"Wang L, Chang J, Buckley A, Spurney R (2019) Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice. Kidney Int 95(2):321\u2013332. https:\/\/doi.org\/10.1016\/j.kint.2018.09.026","journal-title":"Kidney Int"},{"issue":"5","key":"5538_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1681\/ASN.2007080864","volume":"19","author":"S Tran","year":"2008","unstructured":"Tran S, Chen YW, Chenier I et al (2008) Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 19(5):943\u2013952. https:\/\/doi.org\/10.1681\/ASN.2007080864","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"5538_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1681\/ASN.2006101124","volume":"18","author":"SL Zhang","year":"2007","unstructured":"Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR (2007) Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 18(7):2105\u20132115. https:\/\/doi.org\/10.1681\/ASN.2006101124","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"5538_CR28","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","volume":"11","author":"M Haas","year":"2011","unstructured":"Haas M, Mirocha J (2011) Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 11(10):2123\u20132131. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03647.x","journal-title":"Am J Transplant"},{"issue":"10","key":"5538_CR29","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00125-015-3700-y","volume":"58","author":"C Lo","year":"2015","unstructured":"Lo C, Shi Y, Chang S et al (2015) Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-\u03b21-induced kidney injury in a mouse model of diabetes. Diabetologia 58(10):2443\u20132454. https:\/\/doi.org\/10.1007\/s00125-015-3700-y","journal-title":"Diabetologia"},{"issue":"11","key":"5538_CR30","doi-asserted-by":"publisher","first-page":"F1335","DOI":"10.1152\/ajprenal.00405.2012","volume":"304","author":"Y Shi","year":"2013","unstructured":"Shi Y, Lo C, Chenier I et al (2013) Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensinconverting enzyme-2 expression in Akita mice. Am J Physiol Renal Physiol 304(11):F1335\u2013F1346. https:\/\/doi.org\/10.1152\/ajprenal.00405.2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"5538_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/aja.1001680308","volume":"168","author":"B Schulte","year":"1983","unstructured":"Schulte B, Spicer S (1983) Histochemical evaluation of mouse and rat kidneys with lectin-horseradish peroxidase conjugates. Am J Anat 168(3):345\u2013362. https:\/\/doi.org\/10.1002\/aja.1001680308","journal-title":"Am J Anat"},{"issue":"1","key":"5538_CR32","doi-asserted-by":"publisher","first-page":"E145","DOI":"10.1152\/ajpendo.00034.2011","volume":"301","author":"J Jun","year":"2011","unstructured":"Jun J, Ma Z, Segar L (2011) Spontaneously diabetic Ins2+\/Akita:apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. J Physiol Endocrinol Metab 301(1):E145\u2013E154. https:\/\/doi.org\/10.1152\/ajpendo.00034.2011","journal-title":"J Physiol Endocrinol Metab"},{"issue":"2","key":"5538_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1210\/en.2017-00752","volume":"159","author":"S Zhao","year":"2018","unstructured":"Zhao S, Ghosh A, Lo C et al (2018) Nrf2 deficiency upregulates intrarenal angiotensin-converting Enzyme-2 and angiotensin 1-7 receptor expression and attenuates hypertension and nephropathy in diabetic mice. Endocrinology 159(2):836\u2013852. https:\/\/doi.org\/10.1210\/en.2017-00752","journal-title":"Endocrinology"},{"issue":"2","key":"5538_CR34","doi-asserted-by":"publisher","first-page":"F419","DOI":"10.1152\/ajprenal.00497.2018","volume":"317","author":"A Onishi","year":"2019","unstructured":"Onishi A, Fu Y, Darshi M et al (2019) Effect of renal tubule-specific knockdown of the Na(+)\/H(+) exchanger NHE3 in Akita diabetic mice. Am J Physiol Renal Physiol 317(2):F419\u2013F434. https:\/\/doi.org\/10.1152\/ajprenal.00497.2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"5538_CR35","doi-asserted-by":"publisher","first-page":"F712","DOI":"10.1152\/ajprenal.00264.2020","volume":"319","author":"A Onishi","year":"2020","unstructured":"Onishi A, Fu Y, Patel R et al (2020) A role for tubular Na(+)\/H(+) exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin. Am J Physiol Renal Physiol 319(4):F712\u2013F728. https:\/\/doi.org\/10.1152\/ajprenal.00264.2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"5538_CR36","doi-asserted-by":"publisher","unstructured":"Borges-Junior FA, Silva Dos Santos D, Benetti A et al (2021) Empagliflozin inhibits proximal tubule NHE3 activity, preserves GFR, and restores Euvolemia in nondiabetic rats with induced heart failure. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2020071029","DOI":"10.1681\/ASN.2020071029"},{"issue":"2","key":"5538_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI8761","volume":"106","author":"S Thomson","year":"2000","unstructured":"Thomson S, Bao D, Deng A, Vallon V (2000) Adenosine formed by 5\u2032-nucleotidase mediates tubuloglomerular feedback. J Clin Invest 106(2):289\u2013298. https:\/\/doi.org\/10.1172\/JCI8761","journal-title":"J Clin Invest"},{"issue":"1","key":"5538_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1523-1755.2002.00093.x","volume":"61","author":"Y Ren","year":"2002","unstructured":"Ren Y, Arima S, Carretero OA, Ito S (2002) Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int 61(1):169\u2013176. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00093.x","journal-title":"Kidney Int"},{"issue":"2","key":"5538_CR39","doi-asserted-by":"publisher","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","volume":"306","author":"V Vallon","year":"2014","unstructured":"Vallon V, Gerasimova M, Rose M et al (2014) SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am J Physiol Renal Physiol 306(2):F194\u2013F204. https:\/\/doi.org\/10.1152\/ajprenal.00520.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"5538_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fphys.2019.00271","volume":"10","author":"S Chung","year":"2019","unstructured":"Chung S, Kim S, Son M et al (2019) Empagliflozin contributes to polyuria via regulation of sodium transporters and water channels in diabetic rat kidneys. Front Physiol 10:271. https:\/\/doi.org\/10.3389\/fphys.2019.00271","journal-title":"Front Physiol"},{"issue":"36","key":"5538_CR41","doi-asserted-by":"publisher","first-page":"27869","DOI":"10.1074\/jbc.M110.133066","volume":"285","author":"P He","year":"2010","unstructured":"He P, Klein J, Yun CC (2010) Activation of Na+\/H+ exchanger NHE3 by angiotensin II is mediated by inositol 1,4,5-triphosphate (IP3) receptor-binding protein released with IP3 (IRBIT) and Ca2+\/calmodulin-dependent protein kinase II. J Biol Chem 285(36):27869\u201327878. https:\/\/doi.org\/10.1074\/jbc.M110.133066","journal-title":"J Biol Chem"},{"issue":"10","key":"5538_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20140329","volume":"128","author":"Y Shi","year":"2015","unstructured":"Shi Y, Lo CS, Padda R et al (2015) Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci (Lond) 128(10):649\u2013663. https:\/\/doi.org\/10.1042\/CS20140329","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"5538_CR43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/ki.2008.408","volume":"74","author":"M Freundlich","year":"2008","unstructured":"Freundlich M, Quiroz Y, Zhang Z et al (2008) Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 74(11):1394\u20131402. https:\/\/doi.org\/10.1038\/ki.2008.408","journal-title":"Kidney Int"},{"issue":"5","key":"5538_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/ki.2014.246","volume":"86","author":"D Cherney","year":"2014","unstructured":"Cherney D, Perkins B, Soleymanlou N et al (2014) Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes. Kidney Int 86(5):1057\u20131058. https:\/\/doi.org\/10.1038\/ki.2014.246","journal-title":"Kidney Int"},{"issue":"2","key":"5538_CR45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jphs.2017.10.006","volume":"137","author":"L Li","year":"2018","unstructured":"Li L, Konishi Y, Morikawa T et al (2018) Effect of a SGLT2 inhibitor on the systemic and intrarenal renin-angiotensin system in subtotally nephrectomized rats. J Pharmacol Sci 137(2):220\u2013223. https:\/\/doi.org\/10.1016\/j.jphs.2017.10.006","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"5538_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000499597","volume":"49","author":"T Woods","year":"2019","unstructured":"Woods T, Satou R, Miyata K et al (2019) Canagliflozin prevents intrarenal angiotensinogen augmentation and mitigates kidney injury and hypertension in mouse model of type 2 diabetes mellitus. Am J Nephrol 49(4):331\u2013342. https:\/\/doi.org\/10.1159\/000499597","journal-title":"Am J Nephrol"},{"key":"5538_CR47","doi-asserted-by":"publisher","first-page":"108107","DOI":"10.1016\/j.diabres.2020.108107","volume":"162","author":"KN Miyata","year":"2020","unstructured":"Miyata KN, Zhao S, Wu CH et al (2020) Comparison of the effects of insulin and SGLT2 inhibitor on the renal renin-angiotensin system in type 1 diabetes mice. Diabetes Res Clin Pract 162:108107. https:\/\/doi.org\/10.1016\/j.diabres.2020.108107","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05538-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:02:25Z","timestamp":1660003345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5538"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05538-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}